Wealthfront Advisers’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.13M Buy
72,433
+11,286
+18% +$910K 0.01% 404
2026
Q1
$4.32M Sell
61,147
-19,732
-24% -$1.48M 0.01% 447
2025
Q4
$6.38M Sell
80,879
-825
-1% -$65.3K 0.01% 346
2025
Q3
$6.73M Sell
81,704
-9,050
-10% -$712K 0.02% 329
2025
Q2
$7.3M Buy
90,754
+1,156
+1% +$89.2K 0.02% 287
2025
Q1
$7.19M Buy
89,598
+5,780
+7% +$481K 0.02% 269
2024
Q4
$6.86M Buy
83,818
+9,840
+13% +$819K 0.02% 247
2024
Q3
$6.1M Buy
73,978
+16,586
+29% +$1.24M 0.02% 259
2024
Q2
$4.03M Buy
57,392
+3,379
+6% +$241K 0.01% 326
2024
Q1
$4M Sell
54,013
-694
-1% -$48.4K 0.01% 321
2023
Q4
$3.62M Sell
54,707
-303
-0.6% -$19K 0.01% 315
2023
Q3
$3.46M Sell
55,010
-10,344
-16% -$644K 0.01% 298
2023
Q2
$3.69M Sell
65,354
-1,580
-2% -$87.7K 0.02% 278
2023
Q1
$3.88M Sell
66,934
-3,667
-5% -$247K 0.02% 254
2022
Q4
$5.11M Sell
70,601
-1,301
-2% -$93.2K 0.02% 195
2022
Q3
$4.37M Sell
71,902
-18,315
-20% -$1.17M 0.02% 199
2022
Q2
$5.67M Sell
90,217
-11,667
-11% -$772K 0.03% 168
2022
Q1
$7.16M Sell
101,884
-17,637
-15% -$1.19M 0.03% 148
2021
Q4
$7.47M Buy
119,521
+21,783
+22% +$1.37M 0.03% 134
2021
Q3
$6.03M Buy
97,738
+20,510
+27% +$1.23M 0.03% 133
2021
Q2
$4.62M Buy
77,228
+13,842
+22% +$877K 0.02% 146
2021
Q1
$3.85M Buy
63,386
+9,326
+17% +$515K 0.02% 148
2020
Q4
$2.54M Sell
54,060
-1,227
-2% -$53.2K 0.02% 180
2020
Q3
$2.06M Buy
55,287
+7,450
+16% +$283K 0.01% 176
2020
Q2
$1.75M Buy
47,837
+4,658
+11% +$162K 0.01% 192
2020
Q1
$1.32M Sell
43,179
-24,685
-36% -$1.09M 0.01% 212
2019
Q4
$3.46M Sell
67,864
-3,708
-5% -$179K 0.03% 109
2019
Q3
$3.38M Sell
71,572
-5,285
-7% -$252K 0.03% 104
2019
Q2
$3.82M Buy
76,857
+16,496
+27% +$775K 0.03% 87
2019
Q1
$2.57M Sell
60,361
-1,346
-2% -$59.5K 0.02% 119
2018
Q4
$2.53M Buy
+61,707
New +$2.65M 0.03% 107

Other funds holding MET

Wealthfront Advisers's MET Position: Q2 2026 in Review

Wealthfront Advisers increased its MetLife (MET) stake by 18% in Q2 2026, buying an estimated $910K and bringing the position to 72,433 shares worth $6.13M. The position accounts for 0.01% of the portfolio, ranked #404.

Wealthfront Advisers first reported a position in MET in Q4 2018 and has held it in 31 quarters since. The position peaked at $7.47M in Q4 2021. 1,445 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Wealthfront Advisers held 72,433 shares of MetLife worth $6.13M as of Q2 2026.
  • Wealthfront Advisers bought 11,286 MetLife shares in Q2 2026, an estimated $910K.
  • MetLife made up 0.01% of Wealthfront Advisers's portfolio in Q2 2026, its #404 holding.
  • Wealthfront Advisers first reported a position in MetLife in Q4 2018 and has held it in 31 quarters since.
  • Wealthfront Advisers's MetLife position peaked at $7.47M in Q4 2021.
  • 1,445 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Wealthfront Advisers's 13F filing for Q2 2026, filed 7 Aug 2026.